SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY financial statements, including revenue, expenses, profit, and loss

The total revenue of 688179 for the last quarter is 97.29 M CNY, and it's 18.19% lower compared to the previous quarter. The net income of Q1 24 is 17.11 M CNY.